Effects of propentofylline, a NGF synthesis stimulator, on alterations in muscarinic cholinergic receptors induced by basal forebrain lesion in rats

Kazuyuki Fuji, Masayuki Hiramatsu, Saori Hayashi, Tsutomu Kameyama, Toshitaka Nabeshima

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Basal forebrain (BF) lesions induced by ibotenic acid produced increases in the Bmax and Kd values of [3H]QNB binding sites in the frontal cortex, parietal cortex, and hippocampus. Twenty-eight-day successive administration of propentofylline (10 and 25 mg/kg, p.o.) significantly reduced the Kd values of [3H]QNB binding sites, to the levels of those in a sham group, in a dose-dependent manner. Moreover, propentofylline (25 mg/kg, p.o.) significantly reduced the Bmax value of [3H]QNB binding sites compared with that in a vehicle-treated BF-lesioned group. These results suggest that successive administration of propentofylline ameliorates changes in muscarinic cholinergic receptors through improving presynaptic cholinergic dysfunction.

Original languageEnglish
Pages (from-to)99-102
Number of pages4
JournalNeuroscience Letters
Volume150
Issue number1
DOIs
Publication statusPublished - 05-02-1993
Externally publishedYes

Fingerprint

Cholinergic Receptors
Muscarinic Receptors
Nerve Growth Factor
Binding Sites
Ibotenic Acid
Parietal Lobe
Frontal Lobe
Cholinergic Agents
Hippocampus
propentofylline
Basal Forebrain

All Science Journal Classification (ASJC) codes

  • Neuroscience(all)

Cite this

@article{22620e94c3e7414db1ac785014bfb7f7,
title = "Effects of propentofylline, a NGF synthesis stimulator, on alterations in muscarinic cholinergic receptors induced by basal forebrain lesion in rats",
abstract = "Basal forebrain (BF) lesions induced by ibotenic acid produced increases in the Bmax and Kd values of [3H]QNB binding sites in the frontal cortex, parietal cortex, and hippocampus. Twenty-eight-day successive administration of propentofylline (10 and 25 mg/kg, p.o.) significantly reduced the Kd values of [3H]QNB binding sites, to the levels of those in a sham group, in a dose-dependent manner. Moreover, propentofylline (25 mg/kg, p.o.) significantly reduced the Bmax value of [3H]QNB binding sites compared with that in a vehicle-treated BF-lesioned group. These results suggest that successive administration of propentofylline ameliorates changes in muscarinic cholinergic receptors through improving presynaptic cholinergic dysfunction.",
author = "Kazuyuki Fuji and Masayuki Hiramatsu and Saori Hayashi and Tsutomu Kameyama and Toshitaka Nabeshima",
year = "1993",
month = "2",
day = "5",
doi = "10.1016/0304-3940(93)90117-4",
language = "English",
volume = "150",
pages = "99--102",
journal = "Neuroscience Letters",
issn = "0304-3940",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

Effects of propentofylline, a NGF synthesis stimulator, on alterations in muscarinic cholinergic receptors induced by basal forebrain lesion in rats. / Fuji, Kazuyuki; Hiramatsu, Masayuki; Hayashi, Saori; Kameyama, Tsutomu; Nabeshima, Toshitaka.

In: Neuroscience Letters, Vol. 150, No. 1, 05.02.1993, p. 99-102.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Effects of propentofylline, a NGF synthesis stimulator, on alterations in muscarinic cholinergic receptors induced by basal forebrain lesion in rats

AU - Fuji, Kazuyuki

AU - Hiramatsu, Masayuki

AU - Hayashi, Saori

AU - Kameyama, Tsutomu

AU - Nabeshima, Toshitaka

PY - 1993/2/5

Y1 - 1993/2/5

N2 - Basal forebrain (BF) lesions induced by ibotenic acid produced increases in the Bmax and Kd values of [3H]QNB binding sites in the frontal cortex, parietal cortex, and hippocampus. Twenty-eight-day successive administration of propentofylline (10 and 25 mg/kg, p.o.) significantly reduced the Kd values of [3H]QNB binding sites, to the levels of those in a sham group, in a dose-dependent manner. Moreover, propentofylline (25 mg/kg, p.o.) significantly reduced the Bmax value of [3H]QNB binding sites compared with that in a vehicle-treated BF-lesioned group. These results suggest that successive administration of propentofylline ameliorates changes in muscarinic cholinergic receptors through improving presynaptic cholinergic dysfunction.

AB - Basal forebrain (BF) lesions induced by ibotenic acid produced increases in the Bmax and Kd values of [3H]QNB binding sites in the frontal cortex, parietal cortex, and hippocampus. Twenty-eight-day successive administration of propentofylline (10 and 25 mg/kg, p.o.) significantly reduced the Kd values of [3H]QNB binding sites, to the levels of those in a sham group, in a dose-dependent manner. Moreover, propentofylline (25 mg/kg, p.o.) significantly reduced the Bmax value of [3H]QNB binding sites compared with that in a vehicle-treated BF-lesioned group. These results suggest that successive administration of propentofylline ameliorates changes in muscarinic cholinergic receptors through improving presynaptic cholinergic dysfunction.

UR - http://www.scopus.com/inward/record.url?scp=0027208902&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027208902&partnerID=8YFLogxK

U2 - 10.1016/0304-3940(93)90117-4

DO - 10.1016/0304-3940(93)90117-4

M3 - Article

C2 - 8469410

AN - SCOPUS:0027208902

VL - 150

SP - 99

EP - 102

JO - Neuroscience Letters

JF - Neuroscience Letters

SN - 0304-3940

IS - 1

ER -